Masumoto, Nami
Oshikata, Chiyako
Nakadegawa, Ryo
Motobayashi, Yuto
Osada, Reeko
Manabe, Saki
Kaneko, Takeshi
Tsurikisawa, Naomi
Article History
Received: 26 December 2022
Accepted: 27 April 2023
First Online: 13 May 2023
Declarations
:
: The hospital ethics committee of each hospital approved the study in accordance with the Helsinki Declaration. Written informed consent was obtained from all patients or their legal representatives. The ethics approval number at Hiratsuka City Hospital is No. 30-013, and that at National Hospital Organization Yokohama Medical Center is No. 2022-06.
: Consent for publication was obtained from all patients.
: N. Masumoto, C. Oshikata, R. Nakadegawa, Y. Motobayashi, R. Osada, S. Manabe, and T. Kaneko have no conflicts of interest to disclose regarding this study. N. Tsurikisawa received a lecture fees from GlaxoSmithKline Co., Ltd., and Teijin Healthcare Co., Ltd.